BIONORDIKA DENMARK A/S: Financial statements 2022
CVR: 17150774
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIONORDIKA DENMARK A/S (CVR 17150774) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 54,814,040 and a net result of DKK 36,371,701 compared with DKK 65,041,248 the year before. That is a decrease of 40.7% compared with the year before. Equity in the 2022 report amounted to DKK 59,067,612. The solvency ratio was 90.6%. The company had 11 employees in the financial year.
- Gross Profit
- DKK 54,814,040
- Profit/Loss
- DKK 36,371,701
- Equity
- DKK 59,067,612
- Total Assets
- DKK 65,227,803
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 54.8M | 36.4M | 59.1M | 11 |
| 2021 | - | 92.5M | 65M | 87.7M | 11 |
| 2020 | - | 43.4M | 28M | 29.7M | 10 |
| 2019 | - | 9.8M | 2.6M | 4.7M | 10 |
| 2018 | - | 8.9M | 2.9M | 5.1M | - |
Official annual report
Keep an eye on BIONORDIKA DENMARK A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BIONORDIKA DENMARK A/S has published its annual report for 2021. Gross profit came to DKK 92,470,457, and the net result was DKK 65,041,248.
As of February 18, 2022, Peter Simonsbacka has joined the board of directors of BIONORDIKA DENMARK A/S.
As of February 18, 2022, Rolf Mattias Bengtsson has joined the board of directors of BIONORDIKA DENMARK A/S.
As of February 17, 2022, Peter Simonsbacka has left the board of directors of BIONORDIKA DENMARK A/S.
About BIONORDIKA DENMARK A/S
BIONORDIKA DENMARK A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1993. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named MEDINOVA SCIENTIFIC A/S and ApS KBUS 38 NR. 2890. The management consists of Kirsten Skovmøller Lysemose. The board consists of Jussi Sakari Kurittu (chair), Haakon Rivertz Torgersen, Kirsten Skovmøller Lysemose and Michael Hartmann. The company is owned by BioNordika Holding AB. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 14,623,391 and a net result of DKK 4,736,523 compared with DKK 6,279,422 the year before. Equity in the 2025 report amounted to DKK 23,840,415.
